European Endocrinology - Volume 5 - Issue 1

The benefits of preventing 7 million more people from developing diabetes worldwide annually and preventing
complications in the 246 million people with diabetes would be immense. Even though the 2000–2015 UN Millennium
Development Goals do not contain any reference to the impact of non-communicable diseases, the UN General Assembly in
2006 adopted UN Resolution 61/225, which recognised that “diabetes is a chronic, debilitating and costly disease associated
with severe complications, which poses severe risks for families, Member States and the entire world and serious challenges
to the achievement of internationally agreed development goals, including the Millennium Development Goals”. In 2008, the
World Health Assembly endorsed the Action Plan to achieve the recommendations of the 2004 World Health Assembly
Resolution 57/17 (‘Global Strategy on Diet, Physical Activity and Health’). However, despite this, international funding for global
action on non-communicable diseases remains very low.

---

Contents

Forward

Martin Silink
President, International Diabetes Federation (IDF), and Professor, Paediatric Endocrinology, University of Sydney and The Children’s Hospital at Westmead

Current Issues - International Health and Diabetes

Anil Kapur,¹ Anthony D Harries,² Knut Lönnroth,³ Ib C Bygbjerg⁴ and Pierre Lefèbvre⁵
1. Managing Director, World Diabetes Foundation; 2. Senior Advisor, International Union Against Tuberculosis and Lung Diseases; 3. Medical Officer, Stop TB Department, World Health Organization; 4. Professor, Department of International Health, Medical Microbiology and Immunology, University of Copenhagen; 5. Emeritus Professor of Medicine, University of Liège

Felix K Assah¹ and Jean-Claude Mbanya²
1. Doctoral Student, MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge; 2. Professor of Medicine and Endocrinology, Department of Internal Medicine and Specialities, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I

Ann Keeling
Chief Executive Officer and Executive Director, International Diabetes Federation (IDF)

Diabetes Pathophysiology and Genetics

Muhammad A Abdul-Ghani¹ and Ralph A DeFronzo²
1. Assistant Professor of Medicine; 2. Professor of Medicine, and Chief, Division of Diabetes, University of Texas Health Science Center at San Antonio

Vincent Geenen¹ and Olivier Dardenne²
1. Director of Research; 2. Research Associate, Centre of Immunoendocrinology, Institute of Pathology, University of Liège

Clara C Elbers,¹ Marcel GM Wolfs² and Timon W van Haeften^2,3
1. Complex Genetics Section, Department of Biomedical Genetics, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht; 2. Department of Medical Biology, University of Groningen; 3. University Medical Centre Utrecht

Diabetes Management

Guy EHM Rutten¹ and Paul GH Janssen²
1. Professor of Diabetology; 2. General Practitioner, Julius Centre for Health Sciences and Primary Care,
University Medical Centre Utrecht

Incretin Mimetics

Chantal Mathieu
Professor of Medicine, Catholic University Leuven, and Head of Endocrinology, University Hospital Gasthuisberg

Diabetes and Cardiovascular Risk

Sophia Zoungas,¹ John Chalmers² and Anushka Patel3
1. Senior Research Fellow, Cardiovascular and Renal Divisiosn, The George Institute for International Health,
University of Sydney, and School of Public Health, Monash University, Melbourne; 2. Director, Professorial Unit,
The George Institute for International Health, University of Sydney; 3. Director, Cardiovascular Division,
The George Institute for International Health, University of Sydney

Pituitary Disorders

Tomasz E Romer
Endocrinologist, Private Practice, Warsaw

Claire E Higham¹ and Peter J Trainer²
1. Diabetes and Endocrinology Specialist Registrar; 2. Consultant Endocrinologist, Department of Endocrinology, Christie Hospital, Manchester

Harvinder S Chahal,¹ VK Ajith Kumar² and Márta Korbonits³
1. Specialist Registrar in Endocrinology, Centre for Endocrinology, Barts and the London Medical School; 2. Consultant in Clinical Genetics, Clinical Genetics Department, Great Ormond Street Hospital; 3. Professor of Endocrinology and Metabolism, Centre for Endocrinology, Barts and the London Medical School

Thyroid Disorders

Ralf Paschke,¹ Enrico Papini² and Hossein Gharib³
1. Professor of Internal Medicine and Endocrinology, III Medical Department, University of Leipzig; 2. Professor of Endocrinology, University of Rome ‘La Sapienza’ Medical School; 3. Professor of Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic College of Medicine

Luca Persani¹ and Davide Calebiro²
1. Associate Professor of Endocrinology; 2. Post-doctoral Research Fellow, Department of Medical Sciences, University of Milan, and Laboratory of Experimental Endocrinology, IRCCS Istituto Auxologico Italiano

Parathyroid Disorders

Satellite Symposium: ‘Optimal Management of Primary Hyperparathyroidism: What Is the Latest Evidence?’
Held during the 11th European Congress of Endocrinology on 26 April 2009, Istanbul, Turkey

Erectile Dysfunction

Steven Lamm
Clinical Assistant Professor of Medicine, New York University School of Medicine

Pedro Vendeira,^1,2 Carla Costa^2,3,4 and Ronald Virag⁵
1. Department of Urology, S. João Central Hospital, Porto; 2. Association for the Advanced Study of Human Sexuality (iSEX); 3. Department of Biochemistry, Faculty of Medicine, University of Porto; 4. Laboratory for Molecular Cell Biology, Faculty of Medicine, University of Porto; 5. Centre d’Explorations et Traitements de l’Impuissance, Paris